Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated balance sheets

v3.24.0.1
Consolidated balance sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 71,732 $ 77,810
Restricted deposits 10,020 9,814
Accounts receivable, net 47,869 38,141
Deferred contract costs 11,165 9,789
Prepaid expenses and other current assets 5,599 6,628
Total current assets 146,385 142,182
Property and equipment, net 28,630 31,823
Deferred contract costs, non-current 9,845 8,348
Operating lease right-of-use assets 36,007 40,823
Intangible assets, net 4,785 9,561
Goodwill 12,867 12,867
Other non-current assets 494 441
Total assets 239,013 246,045
Current liabilities:    
Borrowings under Credit Facility 25,000 25,000
Accounts payable 8,422 7,144
Payroll and benefit related liabilities 20,437 18,512
Deferred revenue 99,968 93,195
Other payables and accrued expenses 23,263 27,990
Operating lease liabilities 7,095 9,091
Total current liabilities 184,185 180,932
Deferred revenue, non-current 878 974
Operating lease liabilities, non-current 35,329 40,075
Other long-term liabilities 3,074 2,113
Total liabilities 223,466 224,094
Commitments and contingencies (Note 16)
Shareholders' equity    
Ordinary Shares, NIS 0.01 par value 500,000,000 shares authorized as of December 31, 2022 and 2023; 76,435,940 and 78,653,046 shares issued as of December 31, 2022 and 2023, respectively; 76,433,772 and 78,650,878 shares outstanding as of December 31, 2022 and 2023, respectively; 2,168 treasury shares as of December 31, 2022 and 2023; 216 210
Additional paid-in capital 367,558 345,834
Accumulated other comprehensive (loss) income 872 (367)
Accumulated deficit (353,099) (323,726)
Total shareholders' equity 15,547 21,951
Total liabilities and shareholders' equity $ 239,013 $ 246,045
Ordinary shares, authorized (in shares) 500,000,000 500,000,000